Coca-Cola Considers Marijuana-Infused Beverage

Gladys Abbott
September 18, 2018

In a statement, Coca-Cola said it is monitoring the industry and is interested in developing new drinks infused with CBD or cannabidiol - the non-psychoactive ingredient found in cannabis plants which alleviates pain but does not make people high.

"The space is evolving quickly", Coke said.

It says it hasn't made any decisions about using it in coke products.

More than a century after Coca-Cola removed cocaine from its secret formula, the multinational beverage giant is in talks with Canada's Aurora Cannabis to develop cannabis-infused drinks. Just last week, Coke announced a deal to buy Costa Coffee for $5 billion.

The CBD drinks would likely aim to ease inflammation, pain and cramping, the BNN report said https://www.bnnbloomberg.ca/coca-cola-in-talks-with-aurora-to-develop-cannabis-drinks-sources-1.1138528#_gus&_gucid=&_gup=twitter&_gsc=gQCuZEQ. Lagunitas, a craft beer label of Heineken, already has a drink infused with THC, which can be purchased at marijuana dispensaries in California.

Other stocks in the cannabis industry got a boost, with Tilray Inc. adding as much as 9.4 percent in response to Coca-Cola's interest.

More news: Lawyer: Kavanaugh accuser willing to testify publicly

"I don't see this coming up in the trade talks; I do think it's an issue in terms of border management as we've seen come with the news lately", Maryscott Greenwood told BNN Bloomberg in an interview Monday.

Also, in another emailed statement, Heather MacGregor, a spokeswoman with Aurora, alluded to the comoany's interest in the possibility, saying: "As a rule, we do not discuss business development initiatives until they are finalised, however we have a responsibility to our shareholders to give proper consideration to all relevant opportunities that are presented".

While marijuana remains illegal at the national level in the USA, there is growing acceptance of the use of CBD derived from marijuana to treat illnesses ranging from chronic pain to anxiety and epilepsy.

In June, the US Food and Drug Administration approved the epilepsy treatment Epidiolex, the first cannabis-based drug allowed in the United States.

Aurora is Canada's third-largest pot company, with a market value of approximately $7 billion.

Other reports by LeisureTravelAid

Discuss This Article

FOLLOW OUR NEWSPAPER